(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NORMACELL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NORMACELL

ST13

US500000079252372

Class

5

Filing

79252372

Registration

5911244

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

06/30/2026

Trademark type

Word

Nice classes

5

Filing date

01/17/2019

Registration date

11/19/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/05/2026

Last transaction

06/30/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

01

Owner location

BG

Examiner

O'BRIEN, JENNIFER LYNN

Law office

N20

Current location

TMO LAW OFFICE 120

Holders and representatives

Holders

B. A. (pessoa física)
VITALIS PHARMA GmbH

Representatives

Keller & Partner Patentanwälte AG

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the prevention of cell alterations by oxidative stress; medicines for human usemedicinal preparation for normal function of the immune system and protection of cells from oxidative stress; Dietetic substancesDietetic foods and beverages adapted for medical usefood supplements and dietetic preparations in the form of capsules or tabletsadapted for medical use for treatment of disfunctional immune system; medicinal plants extracts for pharmaceutical use; Vitamin and mineral supplements; Decoctions for pharmaceutical purposes for the treatment of disfunctional immune system; medical plant extracts; dried or preserved medical plantsplant extracts for pharmaceutical purposes * Dietary supplement consisting of peptides of porcine spleen proteins and seleniumwhich contributes to the normal functioning of the immune system and to the protection of cells against oxidative stress *

Publications

History of USPTO decisions and trademark events.

37 publications found

C71T

CANCELLED SECTION 71

06/05/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

10/02/2020

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/09/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/03/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/14/2020

FIMP

FINAL DISPOSITION PROCESSED

03/14/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/19/2020

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

01/09/2020

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

01/09/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/09/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/19/2019

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

11/01/2019

PUBO

PUBLISHED FOR OPPOSITION

09/03/2019

GPNX

NOTIFICATION PROCESSED BY IB

08/30/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/14/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/14/2019

NPUB

NOTICE OF PUBLICATION

08/14/2019

ALIE

ASSIGNED TO LIE

07/30/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/22/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/02/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/02/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/02/2019

CNFR

FINAL REFUSAL MAILED

06/24/2019

CNFR

FINAL REFUSAL WRITTEN

06/20/2019

RFNP

REFUSAL PROCESSED BY IB

06/01/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/27/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/27/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/27/2019

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/23/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/25/2019

RFRR

REFUSAL PROCESSED BY MPU

04/25/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/04/2019

CNRT

NON-FINAL ACTION WRITTEN

04/03/2019

DOCK

ASSIGNED TO EXAMINER

03/29/2019

MAFR

APPLICATION FILING RECEIPT MAILED

03/02/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/26/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/21/2019

Continuous trademark protection

Get notified about every new filing that threatens NORMACELL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.